‌

US Patent 7727990 Melanocortin receptor-specific piperazine and keto-piperazine compounds

Patent 7727990 was granted and assigned to Palatin Technologies on June, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Palatin Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77279900

Patent Inventor Names

Yadi Reddy Bonuga0

Shubh D. Sharma0

Zhijun Wu0

Yi-Qun Shi0

Kevin D. Burris0

Papireddy Purma0

Date of Patent

June 1, 2010

Patent Application Number

114640690

Date Filed

August 11, 2006

Patent Primary Examiner

‌

James O. Wilson

Patent abstract

Melanocortin receptor-specific compounds of the general formula

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7727990 Melanocortin receptor-specific piperazine and keto-piperazine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API